Show simple item record

Use of PER977 to reverse the anticoagulant effect of edoxaban.

dc.contributor.author Ansell, JE
dc.contributor.author Bakhru, SH
dc.contributor.author Brown, K
dc.contributor.author Costin, JC
dc.contributor.author Dishy, V
dc.contributor.author Grosso, M
dc.contributor.author Laulicht, BE
dc.contributor.author Noveck, Robert
dc.contributor.author Steiner, SS
dc.coverage.spatial United States
dc.date.accessioned 2015-12-15T16:16:44Z
dc.date.issued 2014-11-27
dc.identifier http://www.ncbi.nlm.nih.gov/pubmed/25371966
dc.identifier.uri https://hdl.handle.net/10161/11170
dc.language eng
dc.relation.ispartof N Engl J Med
dc.relation.isversionof 10.1056/NEJMc1411800
dc.subject Arginine
dc.subject Blood Coagulation
dc.subject Factor Xa Inhibitors
dc.subject Heparin Antagonists
dc.subject Humans
dc.subject Piperazines
dc.subject Pyridines
dc.subject Thiazoles
dc.title Use of PER977 to reverse the anticoagulant effect of edoxaban.
dc.type Journal article
pubs.author-url http://www.ncbi.nlm.nih.gov/pubmed/25371966
pubs.begin-page 2141
pubs.end-page 2142
pubs.issue 22
pubs.organisational-group Duke
pubs.organisational-group Staff
pubs.publication-status Published
pubs.volume 371
dc.identifier.eissn 1533-4406


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record